KD Logo

Ionis Pharmaceuticals Inc [IONS] Shares Fall -1.53 % on Thursday

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ionis Pharmaceuticals Inc shares valued at $4,525 were sold by Monia Brett P on Mar 11 ’25. At $32.32 per share, Monia Brett P sold 140 shares. The insider’s holdings dropped to 180,980 shares worth approximately $5.95 million following the completion of this transaction.

Also, Monia Brett P purchased 140 shares, netting a total of over 4,525 in proceeds.

Before that, O’NEIL PATRICK R. had sold 1,207 shares from its account. In a trade valued at $39,046, the EVP CLO & General Counsel traded Ionis Pharmaceuticals Inc shares for $32.35 each. Upon closing the transaction, the insider’s holdings decreased to 1,207 shares, worth approximately $1.85 million.

As published in a research note from BMO Capital Markets on August 02, 2024, Ionis Pharmaceuticals Inc [IONS] has been rated down from an Outperform to a Market perform and the price target has been revised to $60 from $67. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in late July. Earlier on June 14, 2024, Bernstein upgraded its rating. Their new recommendation was “a Mkt perform” for IONS stock which previously was a “an Underperform”.

Analyzing IONS Stock Performance

During the last five days, there has been a drop of approximately -4.33%. Over the course of the year, Ionis Pharmaceuticals Inc shares have dropped approximately -5.89%. Shares of the company reached a 52-week high of $35.47 on 01/02/25 and a 52-week low of $30.23 on 02/13/25. A 50-day SMA is recorded $32.91, while a 200-day SMA reached $39.65.

Support And Resistance Levels for Ionis Pharmaceuticals Inc (IONS)

According to the 24-hour chart, there is a support level at 32.44, which, if violated, would cause prices to drop to 31.98. In the upper region, resistance lies at 33.60. The next price resistance is at 34.30. RSI (Relative Strength Index) is 50.50 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.32, which suggests the price will decrease in the coming days. Percent R is at 52.37%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular